Surge In Prevalence Of Human Pelvic Floor Disorders Such As Faecal Incontinence Is Expected To Boost The Market Growth
07 Sep 2022
Acquisition
The U.S. accounted for 92.5% of the North American pelvic floor diagnostics market in 2021 owing to the rising prevalence of faecal incontinence in the population.
Fact.MR – A Market Research and Competitive Intelligence Provider: The market was valued at US$ 164. 2 Million and is expected to witness a 5.4% CAGR during forecast period (2022-2032). Moreover, market has also led to 1.5% share of the global gynecology devices market in 2021.
Various factors such as increasing prevalence of human pelvic disorders such as pelvic organ prolapse, faecal incontinence are driving the growth of the market. People suffering from obesity have higher chances of faecal incontinence. Obesity leads to extra weight in the abdomen, which eventually puts pressure on the pelvic floor muscles. This pressure subsequently causes the weakening of muscles and incontinence, either faecal or urinary.
Moreover, obesity and disorders related to overweight are becoming a health concern in various economies across the globe. As per World Health Organization (WHO), ~2.8 million people die every year due to overweight and obesity problems.
Various factors such as rising birth rates in countries such as Germany is expected to boost pelvic organ prolapse. As per privately owned data technology company, Knoema, the number of births in Germany was 789.91 per thousand in 2020 when compared to 771.43 per thousand in the U.K.
For more insights into the Market, Request Brochure of this Report
Besides this, other factors such as ageing of the population and gradually rising life expectancy will fuel demand for healthcare services. For instance, WHO in China projects that by 2040, 28% of the country’s population would be over 60 years of age.
For instance, as per recent NCBI article in 2020, the high prevalence rate of fecal incontinence among the rural elderly Chinese population was around 12.3%.
For Comprehensive Insights Ask An Analyst Here
Market Trends:
High focus on distribution agreements and exclusive partnerships is witnessed among key players in the market
Key players in the market are putting emphasis on exclusive partnerships with local distributors to reach a large customer base.
For instance:
In April 2022, Laborie, medical company, acquired GI Supply, leader in specialty endoscopy and paracentesis products. This acquisition is expected to support Laborie offer a broad range of gastroenterology products to healthcare practitioners, thus increasing its consumer base.
Surge in prevalence of pelvic floor disorders in developed economies such as US
The US accounted for 92.5% of the North American pelvic floor diagnostics owing to the rising prevalence of faecal incontinence. High demand for pelvic floor diagnostics is rising due to surge in prevalence of human pelvic floor disorders, including fecal incontinence and pelvic organ prolapse. These factors are pushing market players to offer upgraded treatments for pelvic health problems.
For instance:
Laborie, manufacturer based in the US, offers cutting-edge medical equipment and supplies for gynecology, urology, colorectal, and gastrointestinal procedures, as well as the diagnosis and treatment of pelvic health problems. It focuses on making investments in new technology, purchasing diverse companies, and utilizing their unique selling proposition.
By product type, Anorectal Manometry systems are gaining traction
The anorectal manometry systems segment had occupied nearly 50% of the global market share in 2021. Moreover, this segment is expected to witness a CAGR of 6.9% during the forecast period. Moreover, high demand is mainly due to increasing diagnostics of human pelvic floor disorders.
Competitive Landscape:
To establish market share, key manufacturers in the market are involved in distribution agreements, acquisitions, and mergers.
In January 2022, Premier, Inc. offered Medspira a group purchasing agreement that went into effect on February 1, 2022.
In April 2017, Diversatek Inc. combined two of its subsidiaries - Sandhill Scientific and Medovations - to form Diversatek Healthcare.
Get Customization on this Report for Specific Research Solutions
Key Companies Profiled by Fact.MR
Laborie, Inc.
Medtronic Plc
Medspira
The Prometheus Group
Diversatek, Inc.
Alacer Biomédica
Mui Scientific
THD SpA
Stericom
MEDICA S.P.A.
By Product:
Anorectal Manometry Systems
Standard Anorectal Manometry Systems
High-Resolution Anorectal Manometry (HRAM) Systems
Handheld Wireless Anorectal Manometry Systems
Anorectal Manometry Catheters
Air Charged Catheters
Solid State Catheters
Water Filled Catheters
Single-Use Water Fused HARM Catheters
Multiple-Use Water Fused HARM Catheters
Anorectal Expulsion Balloon Catheters
Single-Lumen Catheters
Double-Lumen Catheter
By Indication:
Constipation
Faecal Incontinence
Rectocele
Enterocele
By End User:
Hospitals
Diagnostic Imaging Centers
Specialty Clinic
By Region:
North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa (MEA)
Explore Fact.MR’s Coverage on the Healthcare Domain
Blood Cancer Diagnostics Market - Fact.MR has recently updated its analysis of the global blood cancer diagnostics market, and reveals that rising number of affected people and increasing spending on the healthcare sector are the two prime factors driving demand for blood cancer diagnostics.
Lung CancerLung Cancer Diagnostics Market - The global lung cancer diagnostics market revenue to reach US$ 4 Bn by 2031, representing a 2x increase from 2020. Augmented development of lung cancer-specific biomarkers is propelling demand for the lung cancer diagnostics over the forecast period. Revenue from CA tests will account for US$ 1 Bn by 2031-end.
Ovarian Cancer Diagnostics Market - Fact.MR, a market research and competitive intelligence provider, has performed detailed analysis of the industry and researched all the factors that affect market growth. As per the study, the ovarian cancer diagnostics market amassed revenue worth US$ 1.3 Bn in 2020.
Breast Cancer Diagnostics Market - The global breast cancer diagnostics market is likely to acquire a market value of US$ 4 Bn in 2022 and is expected to register a CAGR of 7% by accumulating a market value of US$ 7.9 Bn in the forecast period 2022-2032.
Kidney Cancer Diagnostics Market - The number of people living with kidney cancer has increased rapidly in recent years. Kidney cancer has been observed to occur primarily in the geriatric population, which is expected to drive growth of the global kidney cancer diagnostics market over the coming years and decades.
About Fact.MR
Fact.MR is a market research and consulting agency with deep expertise in emerging market intelligence. Spanning a wide range – from automotive & industry 4.0 to healthcare, technology, chemical and materials, to even the most niche categories. 80% of Fortune 1000's trusts us in critical decision making. We provide both qualitative and quantitative research, spanning market forecast, market segmentation, competitor analysis, and consumer sentiment analysis.
Contact:
Mahendra Singh
US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
E: sales@factmr.com
Follow Us: LinkedIn | Twitter
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Targets
-Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.